Park Medi World Q1 FY27 Earnings Call Transcript Released
Park Medi World Limited released its Q1 FY27 earnings call transcript. The company reported Q1 FY27 revenue of ₹476 crore (up 19% YoY) and PAT of ₹89 crore (up 35% YoY). Key acquisitions include The Medi city Hospital (₹177 crore) and Mehar Hospital (₹107 crore), adding 450 beds by December 2026. FY27 guidance projects revenue at ₹2,080 crore.
The announcement provides detailed financial results and strategic updates, including acquisitions and future guidance, which are material for investors and analysts.
The announcement is a transcript of an earnings call, which provides detailed operational and financial information. While the results show growth, the overall tone is informative rather than overtly positive or negative.
Park Medi World Limited has released the transcript of its Earnings Conference Call held on August 4, 2026, for the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026.
The call featured insights from Dr. Ankit Gupta (Managing Director), Dr. Sanjay Sharma (Whole-Time Director & CEO), Mr. Rajesh Sharma (Group CFO), and Mr. Sudesh Sharma (Chief Strategy Officer & OSD - Finance).
Key highlights from the call include the company's focus on ramping up newer assets in Agra and Panchkula, and advancing growth pipelines in Uttarakhand, NCR, and Punjab. The acquisition of The Medi city Hospital in Rudrapur for approximately ₹177 crore was completed, marking entry into the sixth state. A 100-bed extension, 'Park Platinum', was announced for the Palam Vihar facility. Additionally, an agreement was signed to acquire Mehar Hospital in Zirakpur for approximately ₹107 crore. These additions, totaling 450 beds, are scheduled for commissioning in November and December 2026.
Financial performance for Q1 FY27 showed revenue from operations at ₹476 crore, a 19% year-on-year growth. EBITDA was ₹126 crore (26.5% margin), a 20% year-on-year increase, and PAT stood at ₹89 crore (18.6% margin), a 35% year-on-year growth.
Operational metrics for Q1 FY27 indicated IPD volumes of 26,304 patients (up 16% YoY) and OPD volumes of 2,23,446 patients (up 17% YoY). ARPOB increased by 12% YoY to ₹30,444, and ALOS improved by 8% to 5.9 days.
The company provided guidance for FY27, projecting revenue of ₹2,080 crore, EBITDA of ₹530 crore, and PAT of ₹360 crore, representing growth of 24%, 25%, and 32% respectively. The blended CAPEX per bed is expected to remain at ₹36 lakhs for new facilities over the next two years.
The management also discussed their strategy for integrating new facilities, maintaining affordable healthcare, and their approach to doctor retention, emphasizing clinical outcomes and patient satisfaction over revenue targets.
What to do with a filing like this
Park Medi World Limited filed this with the NSE as a statutory disclosure, categorised under concall transcript released. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Park Medi World Limited. Read the original for the full detail.